Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A in Sjogren's Syndrome Associated Pneumonitis
NCT02370550Phase 4Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2015
- Primary completion
- Mar 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in Sjögren syndrome-associated interstitial lung disease (SS-ILD), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
Sjögren syndrome-associated interstitial lung disease (SS-ILD)
Beyond the preview
Go deeper on NCT02370550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370550.